HLA-A*02:01 & B2M

HLA-A*02:01 & B2M Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
HLM-H82W3
Human
HEK293
Biotinylated Human HLA-A*02:01&B2M Monomer Protein (Peptide free, MALS verified)
Total: 1
  • 1

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
LerapolturevPhase 2 ClinicalNational Cancer Institute, Istari Oncology Inc, Duke University Medical CenterEpendymoma; Medulloblastoma; Solid tumours; Glioblastoma; Oligodendroglioma; Urinary Bladder Neoplasms; Brain Neoplasms; Breast Neoplasms; Gliosarcoma; Astrocytoma; Carcinoma, Embryonal; Glioma; Melanoma
Details
NTX-1088Phase 1 ClinicalNectin Therapeutics LtdSolid tumours; Neoplasms; Neoplasm Metastasis
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland